GLP-1ClinicsNearMe

Weight Loss Clinics in Mobile, Alabama

Looking for a weight loss clinic that prescribes GLP-1 medications? Our directory lists 26 verified providers serving Mobile, Alabama (201,367 residents · 38.9% adult obesity).

Each clinic below offers GLP-1 weight-loss medications including Ozempic, Wegovy, Mounjaro, and Zepbound. Compare ratings, services, and pricing — then book directly or via our partner directory at GLP1Maps.com.

Find Your Clinic ↓Browse Full Directory →

Top 10 GLP-1 Clinics in Mobile

4.7

Medi-Weightloss Mobile — National physician-led weight loss brand. Compounded semaglutide at $99 for first month. Located at 4407 Old Shell Rd, S... 4.7H

OzempicIn-PersonInsurance

Pricing: $99 first month

4

Fast Pace Health Mobile — One of the largest urgent and primary care providers in the Southeast. Offers FDA-approved GLP-1 medications (Wegovy) wi... This directory is for informational purposes only. Not medical advice. Consult your healthcare provider. — TheGLP1Guide.net 13

WegovyTelehealthIn-Person

More GLP-1 Resources

Independent network of GLP-1 resources serving Mobile and patients across the U.S.

What to Look for in a GLP-1 Clinic

Choosing the right GLP-1 provider in Mobile matters. Look for clinics that offer:

GLP-1 Medications Explained

GLP-1 receptor agonists work by mimicking a hormone that regulates appetite and blood sugar. The main options:

Cost & Insurance in Alabama

Alabama Medicaid covers GLP-1 for type 2 diabetes; weight-loss indication generally not covered.

For state regulation info, see the Alabama Medical Board.

Frequently Asked Questions

How many GLP-1 clinics are in Mobile?

Our directory lists 26 verified GLP-1 clinics in the Mobile area, with rankings based on patient reviews, services offered, and verified provider status.

Does insurance cover GLP-1 medications in Alabama?

Alabama Medicaid covers GLP-1 for type 2 diabetes; weight-loss indication generally not covered.

Are compounded GLP-1 medications still available?

Following the FDA's April 2026 503B ruling, compounded semaglutide and tirzepatide are no longer available from most U.S. pharmacies. Most clinics now prescribe FDA-approved Ozempic, Wegovy, Mounjaro, or Zepbound.